It includes monitoring blood sugar levels, following a healthy diet plan, regular physical activity, and sticking to the injection frequency as directed by your healthcare provider
However, this difference was not statistically significant
Novo Nordisk noted it didnt sponsor this study and hasnt had the opportunity to evaluate the data, but said we support research for potential advancements of treatments for patients with Type 1 diabetes as well as other serious chronic conditions. The company isnt pursuing trials of semaglutide for type 1 diabetes itself, but we do continue to support investigator initiated studies, a spokeswoman told CNN by email
Cumulative incidence estimates are based on time from randomization to first EAC-confirmed MACE with non-CV death modeled as competing risk using the Aalen-Johansen estimator
If low or low-normal, use higher dose supplementation or injectable b12
Most patients experience returning appetite, metabolic shifts, and weight regaintypically two-thirds of lost weight within one year
